In this issue of Cancer Cell, Haybaeck et al. unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets.

Original languageEnglish
Pages (from-to)272-273
Number of pages2
JournalCancer Cell
Issue number4
StatePublished - 6 Oct 2009


Dive into the research topics of 'Lymphotoxins: New Targets for Hepatocellular Carcinoma'. Together they form a unique fingerprint.

Cite this